Cite
HARVARD Citation
Kleinman, S. et al. (2013). A patient‐oriented risk–benefit analysis of pathogen‐inactivated blood components: application to apheresis platelets in the United States. Transfusion. 53 (7), pp. 1603-1618. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kleinman, S. et al. (2013). A patient‐oriented risk–benefit analysis of pathogen‐inactivated blood components: application to apheresis platelets in the United States. Transfusion. 53 (7), pp. 1603-1618. [Online].